期刊文献+

CYP2J2*7SNP与心血管疾病相关性的研究现状 被引量:1

Overview on the relationship between CYP2J2*7 SNP and cardiovascular disease
下载PDF
导出
摘要 花生四烯酸的CYP450环氧化物酶(主要是CYP2C和2J亚家族)代谢物EETs具有心血管保护作用,包括血管扩张、抗炎、抗血栓、抗细胞凋亡、促进缺血组织平滑肌细胞生长及血管生成等作用。而基因多态性会导致酶活性的下降或酶合成量的减少,使得相应代谢物合成量减少,并可能与疾病的发生息息相关。因此科研工作者从基因出发,寻找疾病的易感基因,以期从分子水平治疗疾病。CYP450环氧化物酶基因突变的位点很多,仅就其花生四烯酸代谢产物之一EETs在心血管中的作用和CYP2 J2中一个普遍存在且具有功能意义的突变点G-50T(即CYP2 J2*7)单核苷酸多态性与心血管疾病关系的研究现状作一综述。 CYP450 epoxide enzyme(mainly CYP2C and CYP2J subfamily) can metabolize arachidonic acid into EETs which have many cardiovascular protective effect,including expansion vessels,anti-inflammatory,anti-thrombotic,anti-apoptosis,the promotion of ischemic tissue growth and angiogenesis of smooth muscle cells.Gene polymorphism reduces enzyme's amount and makes the corresponding reduction in metabolism synthesis,and may be closely related to some disease.Therefore researchers can look for disease susceptibility genes in order to treat disease from the molecular level.CYP450 has many gene mutations,this article makes a review on the present situation of research in the relationship between CYP2J2*7(commonly exist in CYP2J2 and have meaningful function) and cardiovascular disease.
出处 《生物学杂志》 CAS CSCD 2011年第4期81-83,共3页 Journal of Biology
基金 广东省科技计划项目(2009B080701105)
关键词 细胞色素P450 基因多态性 心血管疾病 CYP2J2 CYP450 gene polymorphism cardiovascular disease CYP2J2
  • 相关文献

参考文献16

  • 1Capdevila J H,Falck J R,Imig J D.Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension[J].Kidney International,2007,72(6):683-689.
  • 2Cai Y.Arachidonic acid cytochrome P4504F2 in hypertension:what can we learn from a transgenic mouse model[J] Kidney International,2009,75 (12):1253-1254.
  • 3King L M,Ma J,Srettabunjong S,et al.Cloning of CYP2J2 gene and identification of functional polymorphisms[J].Moleculer Fhannacology,2002,61(4):840-852.
  • 4Lee S S,Jeong H E,Liu K H,et al.Identification and functional characterization of novel CYP2J2 variants:C312R variant causes loss of enzyme catalytic activity[J].Pharmacogenetics & Genomics,2005,15:105-113.
  • 5Wang H J,Jiang Y,Liu Y,et al.CYP2J2 * 7 single micleoude polymorphism in a Chinese population[J].Clinica Chimica Ada,2006,365(1-2):125-128.
  • 6Zhang Y F,El-Sikhiy H,Chaudhary K R,et al.Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity[J].AJPHeart Circulatory Physiology,2009,297(1):H37-H46.
  • 7Xu D Y,Li N,He Y X,et al.Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors[J].Proceedings of National Academy Sciences of USA,2006,103(49):18733-18738.
  • 8Polonikov A V,Ivanov V P,Solodilova M A,et al.A common polymorphism C-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population[J].Disease Markers,2008,24(2):119-126.
  • 9Dreisbach A W,JapaS,Sigel A,et al.The prevalence of CYP2C8,2C9,2J2,and soluble epoxide hydrolase polymorphisms in African Americans with hypertension[J].American Journal of Hypertension,2005,18(10):1276-1281.
  • 10Liu P Y,Chao T H,Wu H L,et al.Symetgistic effect of cytochrome P450 epoxygenase CYP2J2 '7 polymorphism with smoking on the onset of premature myocardial infarction[J].Atherosclerosis,2007,195:199-206.

二级参考文献2

共引文献2

同被引文献10

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部